(Q40281264)

19 September 2017

title

Experimental metastasis and primary tumor growth in mice with hemophilia A. (English)

1 reference

19 September 2017

0 references

0 references

Langer F

1

1 reference

19 September 2017

Amirkhosravi A

2

1 reference

19 September 2017

Ingersoll SB

3

1 reference

19 September 2017

Walker JM

4

1 reference

19 September 2017

Spath B

5

1 reference

19 September 2017

Eifrig B

6

1 reference

19 September 2017

Bokemeyer C

7

1 reference

19 September 2017

Francis JL

8

1 reference

19 September 2017

publication date

1 May 2006

1 reference

Journal of Thrombosis and Haemostasis

19 September 2017

published in

1 reference

19 September 2017

volume

4

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

1056-1062

1 reference

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Effect of antihemostatic agents on experimental tumor dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Antimetastatic effect of tinzaparin, a low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

21 January 2018

Haemophilias A and B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Role of thrombin in angiogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Regulation of angiogenesis by tissue factor cytoplasmic domain signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

Role of tissue factor in hemostasis, thrombosis, and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01883.X

10.1111/J.1538-7836.2006.01883.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference